APLM

Apollomics Inc. Class A Ordinary Shares (APLM)

Stock · NASDAQ · Health Care

$21.1as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

APLM Moves in Monday's Health Care Stock Rally. Apollomics was among 12 health‑care stocks that moved during Monday’s intraday session, reflecting broader sector momentum. The move shows that APLM is part of a group of companies gaining attention in the health‑care space. The stock remains within its 52‑week range and near its $13.14 support level.

Active signals

Support level
$13.14
Industry
Biotechnology: Pharmaceutical Preparations

What APLM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakout23-0.7%48%
Volume Spike17-1.9%41%
Bollinger Band Breakdown15-14.3%27%
200-Day Moving Average TouchActive now7+0.1%57%
Any 20-session window (baseline)-3.5%44%

Computed by MarketWall from daily closing prices since September 13, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About APLM

Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other sol…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
14

Fundamentals

1-day range
$21$21.21
Market cap
$37.33M
P/E (trailing)
—
P/E (forward)
-32.46
EPS (trailing)
$-18.93
Dividend yield
—
Beta
1.36
Avg. volume
15.5K
52-week range
$10.01$42.12

Apollomics Inc. Class A Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • APLM
    Apollomics Inc. Class A Ordinary Shares
    $21.1
    ▲ 0.48%
    Market cap $37.33MP/E —
    $10.01$42.12
  • CRVO
    CervoMed Inc. Common Stock
    $2.24
    ▼ 0.44%
    Market cap $37.33MP/E —
    $2.13$10
  • IXHL
    Incannex Healthcare Inc. Common Stock
    $2.82
    ▼ 2.08%
    Market cap $37.21MP/E —
    $2.49$14.91
  • VERU
    Veru Inc. Common Stock
    $2.3
    ▼ 5.74%
    Market cap $37.08MP/E —
    $2.05$7.33
  • BYSI
    BeyondSpring Inc. Ordinary Shares
    $0.559
    ▼ 3.95%
    Market cap $35.77MP/E —
    $0.5657$2.44
  • NNVC
    NanoViricides Inc. Common Stock
    $1.38
    ▲ 0.73%
    Market cap $35.56MP/E —
    $0.85$2.23
  • LTRN
    Lantern Pharma Inc. Common Stock
    $0.668
    ▲ 0.15%
    Market cap $35.47MP/E —
    $0.651$4.58

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
52.0K
Disposed
3.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.